The RISK-IR project aims to contribute to low dose risk ionising radiation research in Europe, providing a better understanding of the magnitude of cancer risk in humans exposed at low radiation doses (those below 100 milli Sieverts). Accordingly, the acronym of the project stands for Risk, Stem Cells and Tissue Kinetics - Ionising Radiation.
This collaborative project represents an endeavour of over 8.5M€ and has been co-funded by the European Commission under the 7th Framework Programme. RISK-IR draws on the expertise of 10 institutions from 7 European countries. The project started in November 2012 and has an expected duration of 4 years.
The primary output of the RISK-IR project will be scientific evidence in the form of peer reviewed scientific papers. This evidence will be consolidated through dissemination of project results and their implications to radiation protection specialists at the stakeholder meeting in the final year of the project.
The RISK-IR project relies on very ambitious European-wide intitiatives, like DoReMi and MELODI.
The European Network of Excellence for Multidisciplinary European Low Dose Initiative (DoReMi) promotes sustainable integration of low dose risk research in Europe, in order to aid effective resolution of key policy questions identified by the High Level Expert Group (HLEG) on Low Dose Risk Research. DoReMi was launched in January 2010 for a duration of six years and with 12 original partners.
DoReMi provides an operational tool for the development of the proposed MELODI platform (Multidisciplinary European Low Dose Risk Research Initiative) consisting of major national bodies and research programmes that have long term commitment in low dose risk research in Europe. In 2010 MELODI was founded as a registerd association of 15 members.